Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
CPI Card Group
PMTS
$261M
| $217K | ﹤0.01% |
+7,792
| New | +$214K |
|
|
VLRS
3102
Controladora Vuela Compania de Aviacion
VLRS
$962M
| $216K | ﹤0.01% |
34,200
-500
| -1% | -$3.05K |
|
|
GHSI
3103
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
| $215K | ﹤0.01% |
38,804
+1,884
| +5% | +$19.1K |
|
|
NUTX
3104
Nutex Health
NUTX
$1.08B
| $215K | ﹤0.01% |
9,898
+4,208
| +74% | +$60.7K |
|
3105
Verrica Pharmaceuticals
VRCA
$94.7M
| $215K | ﹤0.01% |
14,796
+10,243
| +225% | +$461K |
|
|
MOFG
3106
DELISTED
MidWestOne Financial Group
MOFG
| $211K | ﹤0.01% |
7,400
-3,600
| -33% | -$97.7K |
|
3107
iShares Expanded Tech Sector ETF
IGM
$10.6B
| $211K | ﹤0.01% |
+2,200
| New | +$203K |
|
|
EBTC
3108
DELISTED
Enterprise Bancorp
EBTC
| $211K | ﹤0.01% |
6,600
-11,948
| -64% | -$343K |
|
3109
IZEA Worldwide
IZEA
$61.6M
| $211K | ﹤0.01% |
76,703
+1,100
| +1% | +$2.57K |
|
3110
Advanced Energy
AEIS
$13.2B
| $210K | ﹤0.01% |
1,996
-9,626
| -83% | -$1.01M |
|
3111
Xilio Therapeutics
XLO
$59.9M
| $210K | ﹤0.01% |
19,021
-2,050
| -10% | -$25.2K |
|
3112
Avalon Holdings
AWX
$9.94M
| $209K | ﹤0.01% |
82,010
-100
| -0.1% | -$240 |
|
3113
Dare Bioscience
DARE
$20.1M
| $209K | ﹤0.01% |
64,395
-497
| -0.8% | -$1.7K |
|
3114
SIFCO Industries
SIF
$169M
| $208K | ﹤0.01% |
44,834
-700
| -2% | -$2.76K |
|
3115
Fortrea Holdings
FTRE
$1.81B
| $208K | ﹤0.01% |
10,400
-285,200
| -96% | -$6.7M |
|
|
SYRS
3116
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $207K | ﹤0.01% |
96,435
-21,000
| -18% | -$75.4K |
|
|
BERY
3117
DELISTED
Berry Global Group, Inc.
BERY
| $206K | ﹤0.01% |
3,307
-88,754
| -96% | -$5.27M |
|
3118
Vince Holding Corp
VNCE
$83.9M
| $206K | ﹤0.01% |
111,550
-2,900
| -3% | -$4.8K |
|
3119
American Shared Hospital Services
AMS
$9.87M
| $206K | ﹤0.01% |
67,449
+11,948
| +22% | +$37K |
|
3120
Treace Medical Concepts
TMCI
$310M
| $205K | ﹤0.01% |
35,300
-171,200
| -83% | -$1.1M |
|
3121
GH Research
GHRS
$2B
| $203K | ﹤0.01% |
30,400
| – | – |
|
|
CARM
3122
DELISTED
Carisma Therapeutics
CARM
| $203K | ﹤0.01% |
206,757
+67,397
| +48% | +$73K |
|
|
CTHR
3123
DELISTED
Charles & Colvard Ltd
CTHR
| $203K | ﹤0.01% |
117,269
-1,800
| -2% | -$3.15K |
|
|
GOCO
3124
DELISTED
GoHealth
GOCO
| $202K | ﹤0.01% |
21,572
+3,300
| +18% | +$33.4K |
|
|
LONA
3125
LeonaBio Inc
LONA
$72.1M
| $202K | ﹤0.01% |
45,279
+18,130
| +67% | +$425K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.